Brian Tadayoshi Abe is a Stanford, California based male rheumatologist who is specialized in Rheumatology. Active license number of Brian Tadayoshi Abe for Rheumatology is A132224 in California. Brian Tadayoshi Abe treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Brian Tadayoshi Abe speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD, PHD
Gender:
Male
Practice Address:
300 Pasteur Dr Rm 2225, Stanford, California, 94305-2200
Phone:
650-723-7887
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1104262708
NPI Enumeration Date:
22 May, 2013
NPI Last Update On:
13 Jul, 2020
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Brian Tadayoshi Abe are as mentioned below.
License Number
Specialization
State
Status
A132224
Rheumatologist
California
Primary
A132224
Internal Medicine
California
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1000 Welch Rd Ste 203, Palo Alto, California
Zip:
94304-1808
Phone Number:
650-723-6961
Fax Number:
--
Patients can reach Brian Tadayoshi Abe at 300 Pasteur Dr Rm 2225, Stanford, California or can call to book an appointment on 650-723-7887. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.